Company profile
CatenaBio company profile
CatenaBio pioneers protein conjugation technologies for novel therapeutic development. The company focuses on creating innovative, personalized therapeutics using its proprietary CysTyr™ technology. This technology allows precise connection to any site on a protein, facilitating the development of multi-payload conjugates. CatenaBio's advancements have potential applications in biological therapeutics, autoimmune disorders, and vaccine development.
Business identity
- Website
- https://catenabio.com
- Operating status
- Active
- Company type
- For Profit
- Employee range
- 00001-00010 employees
- Revenue range
- $0+
- Founded
- 2020-01-01
Headquarters
- Headquarters
- Berkeley, California, United States
- Postal code
- 94720
- Country code
- US
- Continent
- North America